Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimization of the First-line Therapy of T-cell Lymphomas

NCT07258680 is registered in ClinicalTrials.gov with N.N. Petrov National Medical Research Center of Oncology as lead sponsor.

NCT NCT07258680
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07258680 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimization of the First-line Therapy of T-cell Lymphomas
Lead sponsor
N.N. Petrov National Medical Research Center of Oncology
Phase
Phase 3
Overall status
Enrolling by invitation
Start date
October 31, 2013
Completion date
December 31, 2028
Enrollment
114 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral t-cell lymphoma